Search research articles
Contact Us
Filters
Showing results (101-110 of 282) with videos related to
Page
of 29
Sort By:
Therapeutic Drug Monitoring
|
August 28, 2014
A validated method for quantification of efavirenz in dried blood spots using high-performance liquid chromatography-mass spectrometry
Alieu B Amara, Laura J Else, John Tjia, et al.
The Journal of Antimicrobial Chemotherapy
|
December 19, 2015
Dolutegravir and elvitegravir plasma concentrations following cessation of drug intake
Emilie Elliot, Alieu Amara, Akil Jackson, et al.
Plos One
|
June 4, 2026
The role of premorbid cognitive performance in the neuropsychological assessment of people with HIV in South Africa
Anna J Dreyer, John A Joska, Kevin G F Thomas, et al.
AIDS (London, England)
|
May 31, 2013
Drug-drug interactions between antiretrovirals and drugs used in the management of neglected tropical diseases: important considerations in the WHO 2020 Roadmap and London Declaration on Neglected Tropical Diseases
Kay Seden, Saye Khoo, David Back, et al.
Journal of the International AIDS Society
|
November 14, 2014
Darunavir pharmacokinetics throughout pregnancy and postpartum
John Lambert, Valerie Jackson, Laura Else, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
September 12, 2021
The development and validation of a novel LC-MS/MS method for the simultaneous quantification of Molnupiravir and its metabolite ß-d-N4-hydroxycytidine in human plasma and saliva
Alieu Amara, Sujan Dilly Penchala, Laura Else, et al.
The Journal of Antimicrobial Chemotherapy
|
December 14, 2017
Pharmacokinetics of darunavir/cobicistat and etravirine alone and co-administered in HIV-infected patients
José Moltó, Adrian Curran, Cristina Miranda, et al.
The Journal of Antimicrobial Chemotherapy
|
May 9, 2017
Once-daily atazanavir/cobicistat and darunavir/cobicistat exposure over 72 h post-dose in plasma, urine and saliva: contribution to drug pharmacokinetic knowledge
Emilie R Elliot, Alieu Amara, Nicole Pagani, et al.
Sexually Transmitted Infections
|
March 30, 2021
Evidence of HIV pre-exposure or post-exposure prophylaxis (PrEP/PEP) among blood donors: a pilot study, England June 2018 to July 2019
Heli Harvala, Claire Reynolds, Samreen Ijaz, et al.
The Journal of Antimicrobial Chemotherapy
|
February 20, 2015
A Phase I study to assess the safety, tolerability and pharmacokinetic profile of boceprevir and sildenafil when dosed separately and together, in healthy male volunteers
Borja Mora-Peris, Laura Else, David Goldmeier, et al.
Page
of 29
Search research articles
Search
Showing results (101-110 of 282) with videos related to
Sort By:
Page
of 29
Therapeutic Drug Monitoring
|
August 28, 2014
A validated method for quantification of efavirenz in dried blood spots using high-performance liquid chromatography-mass spectrometry
Alieu B Amara, Laura J Else, John Tjia, et al.
The Journal of Antimicrobial Chemotherapy
|
December 19, 2015
Dolutegravir and elvitegravir plasma concentrations following cessation of drug intake
Emilie Elliot, Alieu Amara, Akil Jackson, et al.
Plos One
|
June 4, 2026
The role of premorbid cognitive performance in the neuropsychological assessment of people with HIV in South Africa
Anna J Dreyer, John A Joska, Kevin G F Thomas, et al.
AIDS (London, England)
|
May 31, 2013
Drug-drug interactions between antiretrovirals and drugs used in the management of neglected tropical diseases: important considerations in the WHO 2020 Roadmap and London Declaration on Neglected Tropical Diseases
Kay Seden, Saye Khoo, David Back, et al.
Journal of the International AIDS Society
|
November 14, 2014
Darunavir pharmacokinetics throughout pregnancy and postpartum
John Lambert, Valerie Jackson, Laura Else, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
September 12, 2021
The development and validation of a novel LC-MS/MS method for the simultaneous quantification of Molnupiravir and its metabolite ß-d-N4-hydroxycytidine in human plasma and saliva
Alieu Amara, Sujan Dilly Penchala, Laura Else, et al.
The Journal of Antimicrobial Chemotherapy
|
December 14, 2017
Pharmacokinetics of darunavir/cobicistat and etravirine alone and co-administered in HIV-infected patients
José Moltó, Adrian Curran, Cristina Miranda, et al.
The Journal of Antimicrobial Chemotherapy
|
May 9, 2017
Once-daily atazanavir/cobicistat and darunavir/cobicistat exposure over 72 h post-dose in plasma, urine and saliva: contribution to drug pharmacokinetic knowledge
Emilie R Elliot, Alieu Amara, Nicole Pagani, et al.
Sexually Transmitted Infections
|
March 30, 2021
Evidence of HIV pre-exposure or post-exposure prophylaxis (PrEP/PEP) among blood donors: a pilot study, England June 2018 to July 2019
Heli Harvala, Claire Reynolds, Samreen Ijaz, et al.
The Journal of Antimicrobial Chemotherapy
|
February 20, 2015
A Phase I study to assess the safety, tolerability and pharmacokinetic profile of boceprevir and sildenafil when dosed separately and together, in healthy male volunteers
Borja Mora-Peris, Laura Else, David Goldmeier, et al.
Page
of 29